Niels_Admin – Page 5

BOM sells shares Van Heinde to Sligro

We advised Brabantse Ontwikkelings Maatschappij (BOM) in the sale of its shares in Van Heinde to Sligro Group. Van Heinde is an innovative foodconcept, combining both retail and hospitality. Sligro Group converted Van Heinde to an EMTÉ 3.0 store, where Brasserie Van Heinde remains centrally located in the store.

Niels_Admin16 March 2016

Charles Eijsbouts Lawyers Track Record

Denhams enters into joint venture with Look Incorporated

We advised Denham The Jeanmaker in creating a joint venture with Look Incorporated (Japan) regarding the use of the Denham brand in Japan.

Niels_Admin4 March 2016

Lawyers Marcel van de Vorst Track Record Venture Capital

Energy Trading Platform Amsterdam (ETPA) receives funding from TenneT

We advised ETPA in connection with the acquisition by TenneT of a 40% interest in ETPA to support the further development of the Energy Trading Platform Amsterdam. ETPA will provide participants with easy access to the electricity market via an independent, automated energy trading platform.

Niels_Admin1 March 2016

Eveline Mutsaers Niels Hofkes Track Record Venture Capital

BOM provides growth financing to Vendinova Group

We advised the Brabantse Ontwikkelings Maatschappij (BOM) for an investment in the Vendinova Group from Nieuwkuijk. Vendinova wants to conquer the (inter)national market with the Soup-Server: the world's first soup dispenser for 100 percent natural, fresh soups.

Niels_Admin4 February 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

BOM Capital invests in Gilde Healthcare

We advised BOM Capital with its investment in Gilde Healthcare IV, an investment fund investing in innovative medical technology companies, digital health and therapeutics in Europe and the US.

Niels_Admin1 February 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

LSP invests in ViCentra

We advised LSP (Life Sciences Partners) with its investment in the Series B financing round of ViCentra, a company developing and commercializing an insulin pump system for diabetes patients. With its Kaleido insulin pump, ViCentra aims to reduce the impact that diabetes can have on daily life. The syndicate, led by LSP with participation from existing investor INKEF, will invest EUR 10 million. The funding will support European commercialization of the Kaleido system and preparations for US market entry.

Niels_Admin20 January 2016

Eveline Mutsaers Track Record Venture Capital

BOM Capital invests in Endeit Capital

We advised BOM Capital with its investment in Endeit Fund II, an investment fund providing growth equity to European internet technology companies.

Niels_Admin1 January 2016

Eveline Mutsaers Lawyers Track Record Venture Capital

Stichting DOEN invests in Zeewaar

We advised Stichting DOEN with its investment in Zeewaar, a company that farms seaweed and produces and sells seaweed products.

Niels_Admin1 January 2016

M&A Niels Hofkes Track Record

Acquisition of Acerta Pharma by Astra Zeneca

We advised BOM Capital on the sale of its shares in Acerta Pharma to Astra Zeneca. BOM Capital was one of the early investors in Acerta Pharma. Astra Zeneca has taken a 55% stake in Acerta Pharma and an option to acquire the remaining 45% interest. This sale is after BioNovion the second successful exit in biotech for BOM Capital in 2015, is the largest in the history of BOM Capital and the largest biotech deal so far in the Netherlands.

Niels_Admin17 December 2015

Eveline Mutsaers Lawyers Track Record Venture Capital

BOM Capital invests in Aglaia Biomedical Ventures

We advised BOM Capital with its investment in Aglaia Oncology Fund II, an investment fund focusing on biomedical companies in the field of oncology.

Niels_Admin1 December 2015